NATIONAL UNIVERSIT;TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE;NATIONAL UNIVERS;JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFEIOUS DISEASES;TOKO YAKUHIN KOGYO CO., LTD.;JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES;KAGOSHIMA UNIVERSITY
The present invention relates to a hepatitis B vaccine composition for nasal mucosa spraying administration, characterized by comprising a hepatitis B antigen and a gel base containing a carboxyl vinyl polymer, and by being applicable to hepatitis B prevention and treatment.